Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Diabetes in pregnancy: management from preconception to the postnatal period

NICE guideline
Reference number: NG3
Published: 25 February 2015
Last updated: 16 December 2020

History

Guidance published

Consultation comments and responses (PDF 1.21 MB)

Published:

16 December 2020
Equality impact assessment 4 (PDF 128 KB)

Published:

16 December 2020
Committee member list (PDF 189 KB)

Published:

16 December 2020

Stakeholder list updated

Stakeholder list (PDF 256 KB)

Published:

15 December 2020

Declaration of interests

Register of interests (PDF 738 KB)

Published:

15 December 2020

Equality and health inequalities assessment

Equality impact assessment 4 (PDF 128 KB)

Published:

30 November 2020

Draft guidance consultation

Draft guidance consultation
Evidence review (PDF 3.34 MB)

Published:

23 September 2020
Comments form (MSWord 38 KB)

Published:

23 September 2020
Draft guideline (PDF 513 KB)

Published:

23 September 2020
Equality impact assessment 1-3 (PDF 134 KB)

Published:

23 September 2020

Committee list updated

Committee member list (PDF 179 KB)

Published:

22 September 2020

Scope published

Final scope (PDF 286 KB)

Published:

20 July 2020

Committee meetings

Committee meeting
Minutes 1 (PDF 178 KB)

Published:

06 December 2019
Minutes 2 (PDF 182 KB)

Published:

16 March 2020
Minutes 3 (PDF 184 KB)

Published:

22 July 2020
Minutes 4 (PDF 208 KB)

Published:

05 September 2020
Minutes 5 (PDF 212 KB)

Published:

05 November 2020
Minutes 6 (PDF 199 KB)

Published:

26 November 2020

Original development on 01 February 2015

Stakeholder list updated
Stakeholder list (PDF 165 KB)

Published:

25 July 2018
Surveillance consultation
Surveillance consultation
Surveillance review proposal (PDF 921 KB)

Published:

17 May 2018
Comments form (MSWord 27 KB)

Published:

17 May 2018
Diabetes in pregnancy (update): equality impact assessment - scoping
Diabetes in pregnancy (update): equality impact assessment - scoping (PDF 71 KB)

Published:

08 November 2012
Diabetes in pregnancy (update): guideline consultation
Diabetes in pregnancy (update): guideline consultation information
Diabetes in pregnancy (update): stakeholder comments table (PDF 894 KB)

Published:

25 February 2015
Diabetes in pregnancy (update): draft NICE guidance (PDF 579 KB)

Published:

10 September 2014
Diabetes in pregnancy (update): full draft guidance (PDF 6.91 MB)

Published:

10 September 2014
Diabetes in pregnancy (update): appendices
Diabetes in pregnancy (update): appendices set 2 (PDF 4.97 MB)

Published:

10 September 2014
Diabetes in pregnancy (update): appendices set 1 (PDF 8.66 MB)

Published:

10 September 2014
Comments proforma information
Diabetes in pregnancy (update): guideline development and consultation
Diabetes in pregnancy (update): guideline development and consultation
Collated search strategies (PDF 1.51 MB)

Published:

11 August 2014
Review questions (PDF 28 KB)

Published:

11 August 2014
Health economic plan (PDF 20 KB)

Published:

11 August 2014
GDG minutes
GDG 9 minutes (PDF 138 KB)

Published:

01 April 2014
GDG 8 minutes (PDF 138 KB)

Published:

04 March 2014
GDG 7 minutes (PDF 144 KB)

Published:

19 November 2013
GDG 6 minutes (PDF 135 KB)

Published:

19 November 2013
GDG 5 minutes (PDF 156 KB)

Published:

17 June 2013
GDG 4 minutes (PDF 155 KB)

Published:

10 May 2013
GDG 3 minutes (PDF 179 KB)

Published:

10 May 2013
GDG 1 minutes (PDF 202 KB)

Published:

10 May 2013
GDG 2 minutes (PDF 176 KB)

Published:

08 April 2013
Guideline Development Group members (PDF 59 KB)

Published:

18 December 2012
Diabetes in pregnancy (update): scoping workshop, consultation and final scope
Diabetes in pregnancy (update): scoping workshop, consultation and final scope
Final scope (PDF 149 KB)

Published:

08 November 2012
Diabetes in pregnancy (update): stakeholder comments (PDF 423 KB)

Published:

07 November 2012
Joint diabetes guidelines: draft scopes consultation information
Type 1 diabetes (update): draft scope (PDF 82 KB)

Published:

04 July 2012
Type 2 diabetes: draft scope (PDF 91 KB)

Published:

04 July 2012
Diabetes in children (update): draft scope (PDF 89 KB)

Published:

04 July 2012
Diabetes in pregnancy (update): draft scope (PDF 101 KB)

Published:

04 July 2012
Type 1 Diabetes (update): list of registered stakeholders (PDF 136 KB)

Published:

24 March 2015
Type 2 diabetes information
Diabetes in pregnancy (update): list of registered stakeholders (PDF 101 KB)

Published:

16 January 2015
Diabetes in children and young people: list of registered stakeholders (PDF 129 KB)

Published:

24 March 2015
Diabetes in pregnancy (update): scoping workshop notes (PDF 217 KB)

Published:

03 July 2012